Who are Oral PTH (1-34)'s main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/oral-pth-1-34.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

Oral PTH (1-34) — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Oral PTH (1-34) (Oral PTH (1-34)) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: PTH receptor agonist. Area: Endocrinology / Bone Metabolism.

phase 3 PTH receptor agonist PTH1 receptor (PTHR1) Endocrinology / Bone Metabolism Small molecule Live · refreshed every 30 min

Target snapshot

Oral PTH (1-34) (Oral PTH (1-34)) — Entera Bio Ltd.. Oral PTH (1-34) activates parathyroid hormone receptors on bone cells to stimulate bone formation and increase bone mineral density.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Oral PTH (1-34) TARGET	Oral PTH (1-34)	Entera Bio Ltd.	phase 3	PTH receptor agonist	PTH1 receptor (PTHR1)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (PTH receptor agonist class)

Entera Bio Ltd. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Oral PTH (1-34) — Competitive Intelligence Brief. https://druglandscape.com/ci/oral-pth-1-34. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab